NDC 80425-0121-01 - Cephalexin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0121
- Requested NDC
- 80425-0121-01
- Package NDCs from labels
- 80425-0121-4, 80425-0121-1, 80425-0121-2, 80425-0121-3, 80425-0121-5, 80425-0121-6, 80425-0121-7, 80425-0121-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-01-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cephalexin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-01-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0121-1 | Cephalexin | 28 in 1 BOTTLE | CAPSULE | 28 | 10 | |
| 80425-0121-2 | Cephalexin | 40 in 1 BOTTLE | CAPSULE | 40 | 10 | |
| 80425-0121-3 | Cephalexin | 30 in 1 BOTTLE | CAPSULE | 30 | 10 | |
| 80425-0121-4 | Cephalexin | 20 in 1 BOTTLE | CAPSULE | 20 | 10 | |
| 80425-0121-5 | Cephalexin | 14 in 1 BOTTLE | CAPSULE | 14 | 10 | |
| 80425-0121-6 | Cephalexin | 5 in 1 BOTTLE | CAPSULE | 5 | 10 | |
| 80425-0121-7 | Cephalexin | 6 in 1 BOTTLE | CAPSULE | 6 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0121 | CEPHALEXIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 10 | Current NDC, Legacy NDC, 7 package rows | 20240119_b6ffe633-dd91-6d49-e053-2a95a90a5ac6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0121-1 | EA - Each | 80425-0121 | b098bd7f-bb96-4b61-a21d-97eace448f0c | 1 | 2023-03-13 |
| 80425-0121-2 | EA - Each | 80425-0121 | 426ea2b8-26c1-43e8-a5b1-1672b92f5233 | 1 | 2023-03-13 |
| 80425-0121-3 | EA - Each | 80425-0121 | 7fc1df44-2cd9-4b79-ae4c-de04aadf60a9 | 1 | 2023-03-13 |
| 80425-0121-4 | EA - Each | 80425-0121 | 565cd629-53b3-43a8-a2d5-ea15be49d06e | 1 | 2023-03-13 |
| 80425-0121-5 | EA - Each | 80425-0121 | d48bfbc1-a630-44dc-a60e-afcb09a91657 | 1 | 2023-03-13 |
| 80425-0121-6 | EA - Each | 80425-0121 | 2aca4026-c892-49c5-a382-fcec45451772 | 1 | 2023-10-16 |
| 80425-0121-7 | EA - Each | 80425-0121 | dd7a169c-9ad3-407c-8d7b-6183f03ecc0e | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 88a744d8-a95e-4c63-8b25-52f5039b6ba1 | 2025-09-17 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 8d7f247a-3b42-4823-96fb-5f5c1bd94d49 | 2025-08-29 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 1bfa8744-24ee-4c70-845c-c532b8084433 | 2025-07-29 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 0aad51b4-86d5-e312-e063-6394a90a250d | 2025-07-08 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 50f0187b-09e7-4c11-970f-91cd1877fde1 | 2025-06-03 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 905b3270-abbd-4d5c-b313-3d20eb4b4c57 | 2025-06-03 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | f2e73727-2ab6-4418-9677-19ea1d140bbd | 2025-06-03 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Coupler, LLC | 30b7071e-cef1-bd41-e063-6394a90ad48e | 2025-03-19 | Warnings, Adverse reactions | 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals, Inc. | 28da5822-fb0b-1306-e063-6394a90a6e4c | 2025-03-19 | Warnings, Adverse reactions | 309112 OBN7UDS42Y |
| Orapaz | CEPHALEXIN, IBUPROFEN, CHLORHEXIDINE GLUCONATE | Brisk Pharmaceuticals | 2de0b332-58a3-0bb4-e063-6394a90a1a45 | 2025-02-11 | 309114 | |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 02b5cd6f-3df8-43c1-879d-217fcf55231a | 2025-02-11 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | 12f78d76-ea13-440c-8dd0-5aec86277acf | 2025-01-24 | Warnings, Adverse reactions | 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Cronus Pharma LLC | a4e861e2-5803-4c4a-a962-92f5755e1ab5 | 2025-01-10 | Warnings, Adverse reactions | 309114 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | ADVANCED RX PHARMACY OF TENNESSEE, LLC | af4abf8b-22cc-da58-e053-2a95a90aa766 | 2024-12-31 | Warnings, Adverse reactions | 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | American Health Packaging | cb64cab2-5297-4ed2-a50a-2e5d5e14fa8d | 2024-12-17 | Warnings, Adverse reactions | ANDA090836 309114 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Bryant Ranch Prepack | a8f14231-5d43-46f7-ba1f-d6de8162d5e7 | 2024-11-20 | Warnings, Adverse reactions | OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 99ef59d5-bc44-4727-86fe-dc81357207c3 | 2024-10-25 | Warnings, Adverse reactions | 309114 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 65b38519-1d8a-4aca-b415-c64cca84d085 | 2024-10-25 | Warnings, Adverse reactions | 309114 309112 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Chartwell RX, LLC. | 3c459965-2d42-488b-80c4-ce801f94839c | 2024-10-14 | Warnings, Adverse reactions | ANDA090836 309114 OBN7UDS42Y |
| Cephalexin | CEPHALEXIN | Aurobindo Pharma Limited | e46059e1-3ce9-4a3c-80ce-464b140600ce | 2024-09-28 | Warnings, Adverse reactions | OBN7UDS42Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.